NCT06714591
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06714591
Title Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors SystImmune Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope NOT_YET_RECRUITING Duarte California 91010 United States Details
UCLA Ronald Reagan Medical Center RECRUITING Los Angeles California 90095 United States Details
Yale Cancer Center, Smilow Cancer Hospital at Yale New Haven RECRUITING New Haven Connecticut 06511 United States Details
Moffitt Cancer Center RECRUITING Tampa Florida 33612 United States Details
START Midwest/The Cancer and Hematology Center RECRUITING Grand Rapids Michigan 49546 United States Details
Oncology Hematology Care Clinical Trials, LLC RECRUITING Cincinnati Ohio 45236 United States Details
The Ohio State University Comprehensive Cancer Center RECRUITING Columbus Ohio 43210 United States Details
WVCI Oncology Associates of Oregon RECRUITING Eugene Oregon 24224 United States Details
SCRI -TriStar BMT RECRUITING Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Texas Oncology, P.A. RECRUITING San Antonio Texas 78240 United States Details
Virginia Cancer Specialists RECRUITING Fairfax Virginia 22031 United States Details
Oncology & Hematology Associates of Southwest Virginia, Inc. RECRUITING Roanoke Virginia 24014 United States Details
Fred Hutchinson Cancer Center NOT_YET_RECRUITING Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field